TYRP1, Human (Flanvotumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-TYRP1, Human (Flanvotumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityTYRP1, Human (Flanvotumab biosimilar)
CloneFlanvotumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsELISA, FCM, IP, FuncS, IF, Neut, ICC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human TYRP1 Recombinant Antibody. Flanvotumab, also known as IMC-20D7S, is a human monoclonal antibody designed for the treatment of melanoma. It targets TYRP1. Flanvotumab was developed by ImClone Systems, now owned by Eli Lilly.
Immunogenn/a
Other NamesAnti-TYRP1 Recombinant Antibody, Research Grade Flanvotumab, Anti-Human TYRP1 Recombinant Antibody, 20D7S, IMC-20D7S, Antibody Drug Analogues, Monoclonal Antibody, YR1267, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1188277-05-5
Catalog #YR1267
Priceplease inquire
Order / More InfoTYRP1, Human (Flanvotumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.